skip to content
Imatinib mesylate (Gleevec) for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours Preview this item
ClosePreview this item
Checking...

Imatinib mesylate (Gleevec) for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours

Author: Cancer Care Ontario. Sarcoma Disease Site Group,; Cancer Care Ontario. Program in Evidence-based Care,; Cancer Care Ontario,
Publisher: Toronto, Ontario : Cancer Care Ontario, Beaconsfield, Quebec : Canadian Electronic Library, 2011. 2013.
Series: Evidence-based series (Cancer Care Ontario), no. 11-7, version 2.
Edition/Format:   eBook : Document : State or province government publication : EnglishView all editions and formats
Summary:
"Questions considered: Does treatment with imatinib mesylate (Gleevec) have palliative benefit, in terms of tumour response, disease progression, survival or quality of life, for patients with unresectable or metastatic gastrointestinal stromal tumours (GIST) expressing the KIT tyrosine kinase receptor (identified by CD117 immunohistochemical staining)?"--Guideline review summary.
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Practice Guideline
Electronic books
Material Type: Document, Government publication, State or province government publication, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Cancer Care Ontario. Sarcoma Disease Site Group,; Cancer Care Ontario. Program in Evidence-based Care,; Cancer Care Ontario,
OCLC Number: 860711554
Notes: Cover title.
"Evidence-based Series 11-7 was reviewed in 2011 and endorsed by the Sarcoma Disease Site Group (DSG) on May 31, 2011."
"Release date: September 15, 2011."
Description: 1 online resource (38 pages in various pagings).
Contents: 1. Guideline report overview --
2. Section 1: Clinical practice guideline --
3. Section 2: Systematic review --
4. Section 3: Guideline development and external review --
5. Document assessment and review tool.
Series Title: Evidence-based series (Cancer Care Ontario), no. 11-7, version 2.
Other Titles: EBS 11-7, version 2.
Responsibility: members of the Sarcoma Disease Site Group ; a quality initiative of the Program in Evidence-based Care (PEBC), Cancer Care Ontario (CCO).
More information:

Abstract:

"Questions considered: Does treatment with imatinib mesylate (Gleevec) have palliative benefit, in terms of tumour response, disease progression, survival or quality of life, for patients with unresectable or metastatic gastrointestinal stromal tumours (GIST) expressing the KIT tyrosine kinase receptor (identified by CD117 immunohistochemical staining)?"--Guideline review summary.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/860711554> # Imatinib mesylate (Gleevec) for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours
    a schema:Book, schema:CreativeWork, schema:MediaObject ;
    library:oclcnum "860711554" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/onc> ;
    rdfs:comment "Unknown 'gen' value: sgp" ;
    schema:about <http://experiment.worldcat.org/entity/work/data/3159868144#Topic/pyrimidines_therapeutic_use> ; # Pyrimidines--therapeutic use
    schema:about <http://experiment.worldcat.org/entity/work/data/3159868144#Topic/gastrointestinal_stromal_tumors_chemotherapy> ; # Gastrointestinal stromal tumors--Chemotherapy
    schema:about <http://experiment.worldcat.org/entity/work/data/3159868144#Topic/piperazines_therapeutic_use> ; # Piperazines--therapeutic use
    schema:about <http://experiment.worldcat.org/entity/work/data/3159868144#Topic/gastrointestinal_stromal_tumors_drug_therapy> ; # Gastrointestinal Stromal Tumors--drug therapy
    schema:about <http://dewey.info/class/616.99433/e23/> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/3159868144#Topic/imatinib_therapeutic_use> ; # Imatinib--Therapeutic use
    schema:alternateName "EBS 11-7, version 2." ;
    schema:author <http://viaf.org/viaf/157054577> ; # Cancer Care Ontario,
    schema:bookFormat schema:EBook ;
    schema:contributor <http://viaf.org/viaf/157054577> ; # Cancer Care Ontario,
    schema:copyrightYear "2011" ;
    schema:datePublished "2013" ;
    schema:description "1. Guideline report overview -- 2. Section 1: Clinical practice guideline -- 3. Section 2: Systematic review -- 4. Section 3: Guideline development and external review -- 5. Document assessment and review tool."@en ;
    schema:description ""Questions considered: Does treatment with imatinib mesylate (Gleevec) have palliative benefit, in terms of tumour response, disease progression, survival or quality of life, for patients with unresectable or metastatic gastrointestinal stromal tumours (GIST) expressing the KIT tyrosine kinase receptor (identified by CD117 immunohistochemical staining)?"--Guideline review summary."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/3159868144> ;
    schema:genre "Electronic books"@en ;
    schema:genre "Government publication"@en ;
    schema:genre "Practice Guideline"@en ;
    schema:inLanguage "en" ;
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/3159868144#Series/evidence_based_series_cancer_care_ontario> ; # Evidence-based series (Cancer Care Ontario) ;
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/3159868144#Series/evidence_based_series> ; # Evidence-based series ;
    schema:name "Imatinib mesylate (Gleevec) for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours"@en ;
    schema:productID "860711554" ;
    schema:publisher <http://viaf.org/viaf/157054577> ; # Cancer Care Ontario,
    schema:url <http://books.scholarsportal.info/viewdoc.html?id=/ebooks/ebooks1/gibson_chrc/2013-10-25/1/10746539> ;
    schema:url <http://www.deslibris.ca/ID/238426> ;
    schema:url <http://celarc.ca/cppc/238/238426.pdf> ;
    schema:url <http://site.ebrary.com/id/10746539> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/860711554> ;
    .


Related Entities

<http://celarc.ca/cppc/238/238426.pdf>
    rdfs:comment "PDF (Restricted to University of Ottawa)" ;
    .

<http://experiment.worldcat.org/entity/work/data/3159868144#Series/evidence_based_series> # Evidence-based series ;
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/860711554> ; # Imatinib mesylate (Gleevec) for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours
    schema:name "Evidence-based series ;" ;
    .

<http://experiment.worldcat.org/entity/work/data/3159868144#Series/evidence_based_series_cancer_care_ontario> # Evidence-based series (Cancer Care Ontario) ;
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/860711554> ; # Imatinib mesylate (Gleevec) for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours
    schema:name "Evidence-based series (Cancer Care Ontario) ;" ;
    .

<http://experiment.worldcat.org/entity/work/data/3159868144#Topic/gastrointestinal_stromal_tumors_chemotherapy> # Gastrointestinal stromal tumors--Chemotherapy
    a schema:Intangible ;
    schema:hasPart <http://id.loc.gov/authorities/subjects/sh2006007119> ;
    schema:name "Gastrointestinal stromal tumors--Chemotherapy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/3159868144#Topic/gastrointestinal_stromal_tumors_drug_therapy> # Gastrointestinal Stromal Tumors--drug therapy
    a schema:Intangible ;
    schema:name "Gastrointestinal Stromal Tumors--drug therapy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/3159868144#Topic/piperazines_therapeutic_use> # Piperazines--therapeutic use
    a schema:Intangible ;
    schema:name "Piperazines--therapeutic use"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/3159868144#Topic/pyrimidines_therapeutic_use> # Pyrimidines--therapeutic use
    a schema:Intangible ;
    schema:name "Pyrimidines--therapeutic use"@en ;
    .

<http://viaf.org/viaf/157054577> # Cancer Care Ontario,
    a schema:Organization ;
    schema:name "Cancer Care Ontario," ;
    schema:name "Cancer Care Ontario. Program in Evidence-based Care," ;
    schema:name "Cancer Care Ontario. Sarcoma Disease Site Group," ;
    .

<http://www.worldcat.org/title/-/oclc/860711554>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
    schema:about <http://www.worldcat.org/oclc/860711554> ; # Imatinib mesylate (Gleevec) for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours
    schema:dateModified "2018-01-07" ;
    void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.